Canlyniadau Chwilio - Schattenberg, Jörn M.

Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis gan Schattenberg, Jörn M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The Gut Microbiome and Nonalcoholic Steatohepatitis gan Schattenberg, Jörn M.

Cael y testun llawn Cael y testun llawn

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD) gan Schattenberg, Jörn M., Bergheim, Ina

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers gan Schattenberg, Jörn M., Ekstedt, Mattias

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches gan Armandi, Angelo, Schattenberg, Jörn M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic? gan Schattenberg, Jörn M., Emrich, Tilman

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling gan Schattenberg, Jörn M., Czaja, Mark J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Liver injury in COVID-19: The current evidence gan Alqahtani, Saleh A, Schattenberg, Jörn M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Nonalcoholic Fatty Liver Disease in 2020 gan Maher, Jacquelyn J., Schattenberg, Jörn M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

NAFLD in the Elderly gan Alqahtani, Saleh A, Schattenberg, Jörn M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries gan Gairing, Simon Johannes, Schattenberg, Jörn M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass? gan Noureddin, Nabil, Schattenberg, Jörn M., Alkhouri, Naim, Noureddin, Mazen

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation gan Singh, Rajat, Wang, Yongjun, Schattenberg, Jörn M., Xiang, Youqing, Czaja, Mark J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany gan Labenz, Christian, Kostev, Karel, Kaps, Leonard, Galle, Peter R., Schattenberg, Jörn M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany gan Labenz, Christian, Kostev, Karel, Armandi, Angelo, Galle, Peter R., Schattenberg, Jörn M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD) gan Nier, Anika, Huber, Yvonne, Labenz, Christian, Michel, Maurice, Bergheim, Ina, Schattenberg, Jörn M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease gan van Dijk, Anne‐Marieke, Schattenberg, Jörn M., Holleboom, Adriaan G., Tushuizen, Maarten E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders gan Gairing, Simon Johannes, Galle, Peter Robert, Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany gan Tilch, Marie-Kristin, Galle, Peter R., Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease gan Kaps, Leonard, Labenz, Christian, Galle, Peter R, Weinmann-Menke, Julia, Kostev, Karel, Schattenberg, Jörn M

Cael y testun llawn Cael y testun llawn Cael y testun llawn